A Phase II Study of OSI-774 (Tarceva) and Gemcitabine for Patients With Metastatic Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 05 Nov 2011 Actual end date (January 2009) added as reported by ClinicalTrials.gov.
- 05 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.